What is Krystexxa?
Krystexxa (pegloticase) is a prescription biologic medication used to treat chronic gout that has not responded to conventional therapies. It works by breaking down uric acid in the bloodstream, preventing its buildup in joints and tissues. Krystexxa is administered as an intravenous (IV) infusion and is often prescribed alongside methotrexate to improve treatment response and reduce the likelihood of adverse reactions.